This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Kuni Ito - Innovator in Cyanopyrimidine Derivatives
Introduction
Kuni Ito is a notable inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on cyanopyrimidine derivatives. Her research focuses on compounds that exhibit potent adenosine A2a receptor agonistic activity, which has important implications for various therapeutic applications.
Latest Patents
Kuni Ito holds a patent for a novel cyanopyrimidine compound. This invention is characterized by its safe and effective adenosine A2a receptor agonistic activity, making it a valuable addition to the pharmaceutical landscape. The patent showcases her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Kuni Ito is currently employed at Otsuka Pharmaceutical Company, Limited, where she continues to engage in groundbreaking research. Her work at Otsuka has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical innovation.
Collaborations
Some of Kuni Ito's coworkers include Yohei Yuki and Hiroyuki Yamazaki. Their collaborative efforts have fostered a dynamic research environment, leading to advancements in their respective areas of expertise.
Conclusion
Kuni Ito's work in developing cyanopyrimidine derivatives exemplifies her dedication to innovation in the pharmaceutical industry. Her contributions not only highlight her skills as an inventor but also underscore the importance of collaboration in achieving scientific breakthroughs.